Search Results for

As we wrote at the American Prospect in January, Neal should have requested Trump’s tax returns right away and after that easy part of the committee’s job was over, proceeded to more complex oversight. (alas, Neal has not yet taken our advice)

Over the past several years, Trump has repeatedly nominated, and McConnell has confirmed, unpaired Republican nominees to independent agency boards, creating persistent imbalances across the regulatory apparatus.

In the space of just a few weeks, the coronavirus outbreak has called into question almost every aspect of the political consensus of the last few decades. As it turns out, selling government for parts (aka “privatizing” or “reinventing” government), rolling back regulations, starving governing bodies of resources, and holding those who attempt to serve the public good in contempt, has left us exceedingly vulnerable.

By breaking down high-dollar support by sector, this tool encourages users to draw direct lines between big money fundraising and a president’s choices regarding personnel and executive power.

Revolving Door Project Executive Director Jeff Hauser said, “This anti-competitive merger further entrenches Big Pharma at the expense of all Americans. Big Pharma’s playbook here is no less dangerous for having become rote: They hire well-connected revolving door FTC alumni to secure approval for mergers that undermine the public interest. To restore the public interest at the FTC, we will need to end the FTC-to-BigLaw pipeline that has helped bring about an economy that works well for rich investors rather than American consumers or workers.”

Nancy Pelosi shocked onlookers earlier this month when she named freshman Representative Donna Shalala (D-FL) to the CARES Act oversight panel. Shalala had not expressed interest in the position publicly, nor does she possess specialized expertise in financial policy, congressional oversight, or law enforcement. Pelosi’s choice discouraged those holding out hope that a spirited set of appointees could somewhat overcome the panel’s structural disadvantages.

Congressional leaders have finally reached a deal to replenish the SBA COVID response loan programs temporarily after days of negotiations. Putting aside the tragically narrow parameters of this deal, House Democrats should only be acceding to further funding these ill-designed programs after they have secured effective oversight of the Trump Administration’s heretofore bumbling execution of the law.

Donald Trump has consistently been failing the country in dealing with the coronavirus. Due to Trump’s failed public health response, even his treasury secretary acknowledges that we are facing the worst economic collapse since the Great Depression. This is in addition to the prospect of tens of millions of people getting the coronavirus and hundreds of thousands, or even millions, dying.

Today, the Demand Progress Education Fund and Revolving Door Project submitted a complaint to the Securities and Exchange Commission (SEC) requesting that the agency investigate Senator Richard Burr for insider trading.

Trump’s coronavirus speech proves, once and for all, that the emperor is never going to put on clothes. We have a government without anyone meaningfully in charge of anything other than making Trump and his cronies rich. Banning flights from Europe (and excluding the United Kingdom, where the health minister(!) has tested positive for the novel coronavirus and is self-isolating) indicates Trump’s xenophobia is now guided by throwing darts.

We’ve become accustomed, watching the Democratic debates, to hearing the moderators focus on the practicability of candidates’ plans to move to Medicare for All, reform immigration policy, and fight gun violence. Make no mistake, these bills are important. They’re the type of policies a functional Congress would advance, and markers of a candidate’s vision for the country. But the media’s near-exclusive focus on these legislative proposals is deeply flawed.

For the better part of this year, House Democrats have been consumed by a battle over how best to use their newfound power. One side called for impeachment from the start. The other side insisted that Democrats focus on kitchen table issues like health care. But the choice has always been false; the House can and should do both. In addition to the active impeachment inquiry into Trump’s efforts to influence the 2020 election, there should be a second, no less serious impeachment inquiry into Trump’s efforts to undermine Obamacare.

The Joe Biden campaign is short on cash, so short that it has moved from disavowing an outside super PAC earlier this year to throwing the door open to one last week. That begs the question: If Biden is compromising on this stance for a buck, what other things might he be willing to trade for fundraising help? And with whom?